Your browser doesn't support javascript.
loading
Effect of a 3-Week Treatment with GLP-1 Receptor Agonists on Vasoactive Hormones in Euvolemic Participants.
Vukajlovic, Tanja; Sailer, Clara O; Asmar, Ali; Jensen, Boye L; Vogt, Deborah R; Christ-Crain, Mirjam; Winzeler, Bettina.
Affiliation
  • Vukajlovic T; Departments of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
  • Sailer CO; Department of Clinical Research, University of Basel, 4056 Basel, Switzerland.
  • Asmar A; Departments of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
  • Jensen BL; Department of Clinical Research, University of Basel, 4056 Basel, Switzerland.
  • Vogt DR; Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
  • Christ-Crain M; Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, University Hospital of Copenhagen, 2100 Copenhagen, Denmark.
  • Winzeler B; Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, 5230 Odense, Denmark.
J Clin Endocrinol Metab ; 107(6): e2581-e2589, 2022 05 17.
Article in En | MEDLINE | ID: mdl-35134170

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptide-1 Receptor Type of study: Clinical_trials Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucagon-Like Peptide-1 Receptor Type of study: Clinical_trials Limits: Humans Language: En Journal: J Clin Endocrinol Metab Year: 2022 Document type: Article Affiliation country: Country of publication: